2
Sept 28 (Reuters) – Bruker Corporation: * BRUKER ADVANCES FUNCTIONAL PROTEOMICS WITH NOVEL TIMSULTRA AIP AND TIMSOMNI WORKFLOWS FOR DRUG DISCOVERY & DEVELOPMENT AND DISEASE BIOLOGY RESEARCH Source
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)